NF-κB signaling participates in both RANKL- and IL-4-induced macrophage fusion: Receptor cross-talk leads to alterations in NF-κB pathways

Journal of Immunology

Volumn 187, Issue 4, 2011, Pages 1797-1806

  Yu, Minjun ^a,b   Qi, Xiulan ^a   Moreno, Jose L ^a   Farber, Donna L ^b   Keegan, Achsah D ^a  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^b NewYork Presbyterian Hospital   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 4; OSTEOCLAST DIFFERENTIATION FACTOR; PHOSPHOTRANSFERASE; PROTEIN P105; PROTEIN P50; PROTEIN P52; SYNAPTOTAGMIN I; TRANSCRIPTION FACTOR RELB;

ANIMAL CELL; ARTICLE; BONE MARROW CELL; CELL FUSION; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; MACROPHAGE; MOUSE; MULTINUCLEAR CELL; NONHUMAN; OSTEOCLAST; PRIORITY JOURNAL; PROTEIN CROSS LINKING; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; SIGNAL TRANSDUCTION; WILD TYPE;

ANIMALS; BONE MARROW CELLS; CELL FUSION; CELLS, CULTURED; GIANT CELLS; INTERLEUKIN-4; MICE; MICE, KNOCKOUT; NF-KAPPA B; OSTEOCLASTS; PROTEIN-SERINE-THREONINE KINASES; RANK LIGAND;

EID: 80051948129     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1002628     Document Type: Article

References (70)

1. Anderson, J. M. 2000. Multinucleated giant cells. Curr. Opin. Hematol. 7: 40-47. (Pubitemid 30007686)
2. Saginario, C., H. Sterling, C. Beckers, R. Kobayashi, M. Solimena, E. Ullu, and A. Vignery. 1998. MFR, a putative receptor mediating the fusion of macrophages. Mol. Cell. Biol. 18: 6213-6223. (Pubitemid 28500512)
3. Han, X., H. Sterling, Y. Chen, C. Saginario, E. J. Brown, W. A. Frazier, F. P. Lindberg, and A. Vignery. 2000. CD47, a ligand for the macrophage fusion receptor, participates in macrophage multinucleation. J. Biol. Chem. 275: 37984-37992. (Pubitemid 32004920)
4. Yagi, M., T. Miyamoto, Y. Sawatani, K. Iwamoto, N. Hosogane, N. Fujita, K. Morita, K. Ninomiya, T. Suzuki, K. Miyamoto, et al. 2005. DC-STAMP is essential for cell-cell fusion in osteoclasts and foreign body giant cells. J. Exp. Med. 202: 345-351. (Pubitemid 41126951)
5. Sterling, H., C. Saginario, and A. Vignery. 1998. CD44 occupancy prevents macrophage multinucleation. J. Cell Biol. 143: 837-847. (Pubitemid 28512575)
6. Helming, L., J.Winter, and S. Gordon. 2009. The scavenger receptor CD36 plays a role in cytokine-induced macrophage fusion. J. Cell Sci. 122: 453-459.
7. Helming, L., and S. Gordon. 2009. Molecular mediators of macrophage fusion. Trends Cell Biol. 19: 514-522.
8. Van den Bossche, J., P. Bogaert, J. Van Hengel, C. J. Guérin, G. Berx, K. Movahedi, R. Van den Bergh, A. Pereira-Fernandes, J. M. Geuns, H. Pircher, et al. 2009. Alternatively activated macrophages engage in homotypic and heterotypic interactions through IL-4 and polyamine-induced E-cadherin/catenin complexes. Blood 114: 4664-4674.
9. Walsh, N. C., M. Cahill, P. Carninci, J. Kawai, Y. Okazaki, Y. Hayashizaki, D. A. Hume, and A. I. Cassady. 2003. Multiple tissue-specific promoters control expression of the murine tartrate-resistant acid phosphatase gene. Gene 307: 111-123. (Pubitemid 36428867)
10. Hoffmann, A., and D. Baltimore. 2006. Circuitry of nuclear factor kappaB signaling. Immunol. Rev. 210: 171-186.
11. Basak, S., H. Kim, J. D. Kearns, V. Tergaonkar, E. O'Dea, S. L. Werner, C. A. Benedict, C. F. Ware, G. Ghosh, I. M. Verma, and A. Hoffmann. 2007. A fourth IkappaB protein within the NF-kappaB signaling module. Cell 128: 369-381. (Pubitemid 46123518)
12. Iotsova, V., J. Caamaño, J. Loy, Y. Yang, A. Lewin, and R. Bravo. 1997. Osteopetrosis in Mice lacking NF-kappaB1 and NF-kappaB2. Nat. Med. 3: 1285-1289. (Pubitemid 27508833)
13. Gordon, S. 2003. Alternative activation of macrophages. Nat. Rev. Immunol. 3: 23-35. (Pubitemid 37328697)
14. Gordon, S., and F. O. Martinez. 2010. Alternative activation of macrophages: Mechanism and functions. Immunity 32: 593-604.
15. Moreno, J. L., I. Mikhailenko, M. M. Tondravi, and A. D. Keegan. 2007. IL-4 promotes the formation of multinucleated giant cells from macrophage precursors by a STAT6-dependent, homotypic mechanism: Contribution of E-cadherin. J. Leukoc. Biol. 82: 1542-1553. (Pubitemid 350276966)
16. Moreno, J. L., M. Kaczmarek, A. D. Keegan, and M. Tondravi. 2003. IL-4 suppresses osteoclast development and mature osteoclast function by a STAT6-dependent mechanism: Irreversible inhibition of the differentiation program activated by RANKL. Blood 102: 1078-1086. (Pubitemid 36917809)
17. Yagi, M., K. Ninomiya, N. Fujita, T. Suzuki, R. Iwasaki, K. Morita, N. Hosogane, K. Matsuo, Y. Toyama, T. Suda, and T. Miyamoto. 2007. Induction of DC-STAMP by alternative activation and downstream signaling mechanisms. J. Bone Miner. Res. 22: 992-1001. (Pubitemid 351339721)
18. Mangashetti, L. S., S. M. Khapli, and M. R. Wani. 2005. IL-4 inhibits bone-resorbing activity of mature osteoclasts by affecting NF-kappa B and Ca2+ signaling. J. Immunol. 175: 917-925. (Pubitemid 41094975)
19. Abu-Amer, Y. 2001. IL-4 abrogates osteoclastogenesis through STAT6-dependent inhibition of NF-kappaB. J. Clin. Invest. 107: 1375-1385. (Pubitemid 32522031)
20. Wei, S., M. W. Wang, S. L. Teitelbaum, and F. P. Ross. 2002. Interleukin-4 reversibly inhibits osteoclastogenesis via inhibition of NF-kappa B and mitogen-activated protein kinase signaling. J. Biol. Chem. 277: 6622-6630. (Pubitemid 34968463)
21. Cui, W., J. Z. Ke, Q. Zhang, H. Z. Ke, C. Chalouni, and A. Vignery. 2006. The intracellular domain of CD44 promotes the fusion of macrophages. Blood 107: 796-805. (Pubitemid 43076408)
22. Yin, L., L. Wu, H. Wesche, C. D. Arthur, J. M. White, D. V. Goeddel, and R. D. Schreiber. 2001. Defective lymphotoxin-beta receptor-induced NF-kappaB transcriptional activity in NIK-deficient mice. Science 291: 2162-2165. (Pubitemid 32224449)
23. Yu, M., J. L. Moreno, J. P. Stains, and A. D. Keegan. 2009. Complex regulation of tartrate-resistant acid phosphatase (TRAP) expression by interleukin 4 (IL-4): IL-4 indirectly suppresses receptor activator of NF-kappaB ligand (RANKL)-mediated TRAP expression but modestly induces its expression directly. J. Biol. Chem. 284: 32968-32979.
24. Bohuslav, J., V. V. Kravchenko, G. C. Parry, J. H. Erlich, S. Gerondakis, N. Mackman, and R. J. Ulevitch. 1998. Regulation of an essential innate immune response by the p50 subunit of NF-kappaB. J. Clin. Invest. 102: 1645-1652. (Pubitemid 28516249)
25. Shen, C. H., and J. Stavnezer. 1998. Interaction of stat6 and NF-kappaB: Direct association and synergistic activation of interleukin-4-induced transcription. Mol. Cell. Biol. 18: 3395-3404. (Pubitemid 28240512)
26. Wang, Z., B. Zhang, L. Yang, J. Ding, and H. F. Ding. 2008. Constitutive production of NF-kappaB2 p52 is not tumorigenic but predisposes mice to inflammatory autoimmune disease by repressing Bim expression. J. Biol. Chem. 283: 10698-10706.
27. Ryan, J. J., L. J. McReynolds, A. Keegan, L. H. Wang, E. Garfein, P. Rothman, K. Nelms, and W. E. Paul. 1996. Growth and gene expression are predominantly controlled by distinct regions of the human IL-4 receptor. Immunity 4: 123-132. (Pubitemid 26093158)
28. Heissmeyer, V., D. Krappmann, E. N. Hatada, and C. Scheidereit. 2001. Shared pathways of IkappaB kinase-induced SCF(betaTrCP)-mediated ubiquitination and degradation for the NF-kappaB precursor p105 and IkappaBalpha. Mol. Cell. Biol. 21: 1024-1035. (Pubitemid 32114952)
29. May, M. J., F. D'Acquisto, L. A. Madge, J. Glöckner, J. S. Pober, and S. Ghosh. 2000. Selective inhibition of NF-kappaB activation by a peptide that blocks the interaction of NEMO with the IkappaB kinase complex. Science 289: 1550-1554.
30. Novack, D. V., L. Yin, A. Hagen-Stapleton, R. D. Schreiber, D. V. Goeddel, F. P. Ross, and S. L. Teitelbaum. 2003. The IkappaB function of NF-kappaB2 p100 controls stimulated osteoclastogenesis. J. Exp. Med. 198: 771-781. (Pubitemid 37087776)
31. Takayanagi, H., S. Kim, T. Koga, H. Nishina, M. Isshiki, H. Yoshida, A. Saiura, M. Isobe, T. Yokochi, J. Inoue, et al. 2002. Induction and activation of the transcription factor NFATc1 (NFAT2) integrate RANKL signaling in terminal differentiation of osteoclasts. Dev. Cell 3: 889-901. (Pubitemid 35460788)
32. Xiao, G., E. W. Harhaj, and S. C. Sun. 2001. NF-kappaB-inducing kinase regulates the processing of NF-kappaB2 p100. Mol. Cell 7: 401-409. (Pubitemid 32206507)
33. McInnes, A., and D. M. Rennick. 1988. Interleukin 4 induces cultured monocytes/macrophages to form giant multinucleated cells. J. Exp. Med. 167: 598-611. (Pubitemid 18073657)
34. Hirayama, T., S. Dai, S. Abbas, Y. Yamanaka, and Y. Abu-Amer. 2005. Inhibition of inflammatory bone erosion by constitutively active STAT-6 through blockade of JNK and NF-kappaB activation. Arthritis Rheum. 52: 2719-2729. (Pubitemid 41369100)
35. Clarke, C. J., D. A. Taylor-Fishwick, A. Hales, Y. Chernajovsky, K. Sugamura, M. Feldmann, and B. M. Foxwell. 1995. Interleukin-4 inhibits kappa light chain expression and NF kappa B activation but not I kappa B alpha degradation in 70Z/3 murine pre-B cells. Eur. J. Immunol. 25: 2961-2966.
36. Donnelly, R. P., L. J. Crofford, S. L. Freeman, J. Buras, E. Remmers, R. L. Wilder, and M. J. Fenton. 1993. Tissue-specific regulation of IL-6 production by IL-4. Differential effects of IL-4 on nuclear factor-kappa B activity in monocytes and fibroblasts. J. Immunol. 151: 5603-5612. (Pubitemid 23332370)
37. Nelson, G., G. J. Wilde, D. G. Spiller, S. M. Kennedy, D. W. Ray, E. Sullivan, J. F. Unitt, and M. R. White. 2003. NF-kappaB signalling is inhibited by glucocorticoid receptor and STAT6 via distinct mechanisms. J. Cell Sci. 116: 2495-2503. (Pubitemid 36790131)
38. Bennett, B. L., R. Cruz, R. G. Lacson, and A. M. Manning. 1997. Interleukin-4 suppression of tumor necrosis factor alpha-stimulated E-selectin gene transcription is mediated by STAT6 antagonism of NF-kappaB. J. Biol. Chem. 272: 10212-10219. (Pubitemid 27171700)
39. Ohmori, Y., and T. A. Hamilton. 2000. Interleukin-4/STAT6 represses STAT1 and NF-kappa B-dependent transcription through distinct mechanisms. J. Biol. Chem. 275: 38095-38103. (Pubitemid 32004934)
40. Stütz, A. M., and M. Woisetschläger. 1999. Functional synergism of STAT6 with either NF-kappa B or PU.1 to mediate IL-4-induced activation of IgE germline gene transcription. J. Immunol. 163: 4383-4391. (Pubitemid 29474506)
41. Delphin, S., and J. Stavnezer. 1995. Characterization of an interleukin 4 (IL-4) responsive region in the immunoglobulin heavy chain germline epsilon promoter: Regulation by NF-IL-4, a C/EBP Family member and NF-kappa B/p50. J. Exp. Med. 181: 181-192.
42. Thieu, V. T., E. T. Nguyen, B. P. McCarthy, H. A. Bruns, R. Kapur, C. H. Chang, and M. H. Kaplan. 2007. IL-4-stimulated NF-kappaB activity is required for Stat6 DNA binding. J. Leukoc. Biol. 82: 370-379. (Pubitemid 47230649)
43. Zamorano, J., A. L. Mora, M. Boothby, and A. D. Keegan. 2001. NF-kappa B activation plays an important role in the IL-4-induced protection from apoptosis. Int. Immunol. 13: 1479-1487. (Pubitemid 33138108)
44. Porta, C., M. Rimoldi, G. Raes, L. Brys, P. Ghezzi, D. Di Liberto, F. Dieli, S. Ghisletti, G. Natoli, P. De Baetselier, et al. 2009. Tolerance and M2 (alternative) macrophage polarization are related processes orchestrated by p50 nuclear factor kappaB. Proc. Natl. Acad. Sci. USA 106: 14978-14983.
45. Saccani, A., T. Schioppa, C. Porta, S. K. Biswas, M. Nebuloni, L. Vago, B. Bottazzi, M. P. Colombo, A. Mantovani, and A. Sica. 2006. p50 nuclear factor-kappaB overexpression in tumor-associated macrophages inhibits M1 inflammatory responses and antitumor resistance. Cancer Res. 66: 11432-11440. (Pubitemid 46009975)
46. Salmerón, A., J. Janzen, Y. Soneji, N. Bump, J. Kamens, H. Allen, and S. C. Ley. 2001. Direct phosphorylation of NF-kappaB1 p105 by the IkappaB kinase complex on serine 927 is essential for signal-induced p105 proteolysis. J. Biol. Chem. 276: 22215-22222.
47. Lang, V., J. Janzen, G. Z. Fischer, Y. Soneji, S. Beinke, A. Salmeron, H. Allen, R. T. Hay, Y. Ben-Neriah, and S. C. Ley. 2003. betaTrCP-mediated proteolysis of NF-kappaB1 p105 requires phosphorylation of p105 serines 927 and 932. Mol. Cell. Biol. 23: 402-413. (Pubitemid 36008530)
48. Senftleben, U., Y. Cao, G. Xiao, F. R. Greten, G. Krähn, G. Bonizzi, Y. Chen, Y. Hu, A. Fong, S. C. Sun, and M. Karin. 2001. Activation by IKKalpha of a second, evolutionary conserved, NF-kappa B signaling pathway. Science 293: 1495-1499. (Pubitemid 32801552)
49. Xiao, G., M. E. Cvijic, A. Fong, E. W. Harhaj, M. T. Uhlik, M. Waterfield, and S. C. Sun. 2001. Retroviral oncoprotein Tax induces processing of NF-kappaB2/p100 in T cells: Evidence for the involvement of IKKalpha. EMBO J. 20: 6805-6815. (Pubitemid 33134210)
50. Yao, Z., L. Xing, and B. F. Boyce. 2009. NF-kappaB p100 limits TNF-induced bone resorption in mice by a TRAF3-dependent mechanism. J. Clin. Invest. 119: 3024-3034.
51. Soysa, N. S., N. Alles, D. Weih, A. Lovas, A. H. Mian, H. Shimokawa, H. Yasuda, F. Weih, E. Jimi, K. Ohya, and K. Aoki. 2010. The pivotal role of the alternative NF-kappaB pathway in maintenance of basal bone homeostasis and osteoclastogenesis. J. Bone Miner. Res. 25: 809-818.
52. Ganchi, P. A., S. C. Sun, W. C. Greene, and D. W. Ballard. 1993. A novel NF-kappa B complex containing p65 homodimers: Implications for transcriptional control at the level of subunit dimerization. Mol. Cell. Biol. 13: 7826-7835.
53. Parry, G. C., and N. Mackman. 1994. A set of inducible genes expressed by activated human monocytic and endothelial cells contain kappa B-like sites that specifically bind c-Rel-p65 heterodimers. J. Biol. Chem. 269: 20823-20825. (Pubitemid 24266441)
54. McNally, A. K., K. M. DeFife, and J. M. Anderson. 1996. Interleukin-4-induced macrophage fusion is prevented by inhibitors of mannose receptor activity. Am. J. Pathol. 149: 975-985. (Pubitemid 26334181)
55. McNally, A. K., and J. M. Anderson. 2005. Multinucleated giant cell formation exhibits features of phagocytosis with participation of the endoplasmic reticulum. Exp. Mol. Pathol. 79: 126-135. (Pubitemid 41262494)
56. Raveh, D., B. A. Kruskal, J. Farland, and R. A. Ezekowitz. 1998. Th1 and Th2 cytokines cooperate to stimulate mannose-receptor-mediated phagocytosis. J. Leukoc. Biol. 64: 108-113. (Pubitemid 28304683)
57. Jay, S. M., E. Skokos, F. Laiwalla, M. M. Krady, and T. R. Kyriakides. 2007. Foreign body giant cell formation is preceded by lamellipodia formation and can be attenuated by inhibition of Rac1 activation. Am. J. Pathol. 171: 632-640. (Pubitemid 47344695)
58. Jay, S. M., E. A. Skokos, J. Zeng, K. Knox, and T. R. Kyriakides. 2010. Macrophage fusion leading to foreign body giant cell formation persists under phagocytic stimulation by microspheres in vitro and in vivo in mouse models. J. Biomed. Mater. Res. A 93: 189-199.
59. Varin, A., S. Mukhopadhyay, G. Herbein, and S. Gordon. 2010. Alternative activation of macrophages by IL-4 impairs phagocytosis of pathogens but potentiates microbial-induced signalling and cytokine secretion. Blood 115: 353-362.
60. Papadimitriou, J. M., T. A. Robertson, and M. N. Walters. 1975. An analysis of the Phagocytic potential of multinucleate foreign body giant cells. Am. J. Pathol. 78: 343-358.
61. Morais, J. M., F. Papadimitrakopoulos, and D. J. Burgess. 2010. Biomaterials/tissue interactions: Possible solutions to overcome foreign body response. AAPS J. 12: 188-196.
62. Kellermeyer, R. W., and K. S. Warren. 1970. The role of chemical mediators in the inflammatory response induced by foreign bodies: Comparison with the schistosome egg granuloma. J. Exp. Med. 131: 21-39.
63. Higgins, D. M., R. J. Basaraba, A. C. Hohnbaum, E. J. Lee, D. W. Grainger, and M. Gonzalez-Juarrero. 2009. Localized immunosuppressive environment in the foreign body response to implanted biomaterials. Am. J. Pathol. 175: 161-170.
64. Luttikhuizen, D. T., M. C. Harmsen, and M. J. Van Luyn. 2006. Cellular and molecular dynamics in the foreign body reaction. Tissue Eng. 12: 1955-1970. (Pubitemid 44162854)
65. Zhao, Q., N. Topham, J. M. Anderson, A. Hiltner, G. Lodoen, and C. R. Payet. 1991. Foreign-body giant cells and polyurethane biostability: In vivo correlation of cell adhesion and surface cracking. J. Biomed. Mater. Res. 25: 177-183.
66. Boynton, E. L., M. Henry, J. Morton, and J. P. Waddell. 1995. The inflammatory response to particulate wear debris in total hip arthroplasty. Can. J. Surg. 38: 507-515. (Pubitemid 26024415)
67. Andrade, Z. A. 2009. Schistosomiasis and liver fibrosis. Parasite Immunol. 31: 656-663.
68. Jankovic, D., M. C. Kullberg, N. Noben-Trauth, P. Caspar, J. M. Ward, A. W. Cheever, W. E. Paul, and A. Sher. 1999. Schistosome-infected IL-4 receptor knockout (KO) mice, in contrast to IL-4 KO mice, fail to develop granulomatous pathology while maintaining the same lymphokine expression profile. J. Immunol. 163: 337-342. (Pubitemid 29295858)
69. Auphan, N., J. A. DiDonato, C. Rosette, A. Helmberg, and M. Karin. 1995. Immunosuppression by glucocorticoids: Inhibition of NF-kappa B activity through induction of I kappa B synthesis. Science 270: 286-290.
70. Pyrrho, Ados. S., J. A. Ramos, R. M. Neto, C. S. Silva, H. L. Lenzi, C. M. Takiya, and C. R. Gattass. 2002. Dexamethasone, a drug for attenuation of Schistosoma mansoni infection morbidity. Antimicrob. Agents Chemother. 46: 3490-3498.